{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:52:06Z","timestamp":1780419126703,"version":"3.54.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s42000-018-0086-5","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T09:28:28Z","timestamp":1543310908000},"page":"7-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Vitamin D basis of Alzheimer\u2019s disease: from genetics to biomarkers"],"prefix":"10.1007","volume":"18","author":[{"given":"Erdin\u00e7","family":"Dursun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Gezen-Ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"86_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ana.410300310","volume":"30","author":"WA Rocca","year":"1991","unstructured":"Rocca WA, Hofmann A, Brayne C, Breteler MM, Clarke M, Copeland JR, Dartigues JF, Engedal K, Hagnell O, Heeren TJ (1991) Frequency and distribution of Alzheimer\u2019s disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalance Research Group. Ann Neurol 30:381\u2013390","journal-title":"Ann Neurol"},{"key":"86_CR2","doi-asserted-by":"publisher","first-page":"x","DOI":"10.1007\/978-3-0348-7842-5","volume-title":"Alzheimer Disease Neuropsychology and Pharmacology","author":"G Emilien","year":"2004","unstructured":"Emilien G, Durlach C, Minaker KL, Winblad B, Gauthier S, Maloteaux JM (2004) Introduction. In: Alzheimer Disease Neuropsychology and Pharmacology. Brighauser Verlag, Basel, pp x\u2013xxiv"},{"key":"86_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0166-2236(96)01030-2","volume":"20","author":"J Hardy","year":"1997","unstructured":"Hardy J (1997) Amyloid, the presenilins and Alzheimer\u2019s disease. Trends Neurosci 20:154\u2013159","journal-title":"Trends Neurosci"},{"issue":"1","key":"86_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neuron.2006.09.016","volume":"52","author":"J Hardy","year":"2006","unstructured":"Hardy J (2006) A hundred years of Alzheimer\u2019s disease research. Neuron 52(1):3\u201313","journal-title":"Neuron"},{"issue":"2","key":"86_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jalz.2012.02.001","volume":"8","author":"Alzheimer's Association","year":"2012","unstructured":"Alzheimer's Association (2012) 2012 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 8(2):131\u2013168","journal-title":"Alzheimers Dement"},{"issue":"2","key":"86_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3233\/JAD-131970","volume":"40","author":"D Gezen-Ak","year":"2014","unstructured":"Gezen-Ak D, Yilmazer S, Dursun E (2014) Why vitamin D in Alzheimer\u2019s disease? The hypothesis. J Alzheimers Dis 40(2):257\u2013269","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"86_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1152\/physrev.00014.2015","volume":"96","author":"S Christakos","year":"2016","unstructured":"Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G (2016) Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev 96(1):365\u2013408","journal-title":"Physiol Rev"},{"key":"86_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.yfrne.2009.04.002","volume":"30","author":"M Cekic","year":"2009","unstructured":"Cekic M, Sayeed I, Stein DG (2009) Combination treatment with progesterone and vitamin d hormone may be more effective than monotherapy for nervous system injury and disease. Front Neuroendocrinol 30:158\u2013172","journal-title":"Front Neuroendocrinol"},{"issue":"3","key":"86_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1043-2760(01)00547-1","volume":"13","author":"E Garcion","year":"2002","unstructured":"Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13(3):100\u2013105","journal-title":"Trends Endocrinol Metab"},{"key":"86_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/8756-3282(95)00195-J","volume":"17","author":"M Holick","year":"1995","unstructured":"Holick M (1995) Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications. Bone 17:107\u2013111","journal-title":"Bone"},{"issue":"10","key":"86_CR11","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s10072-016-2647-1","volume":"37","author":"E Dursun","year":"2016","unstructured":"Dursun E, Alaylioglu M, Bilgic B, Hanagasi H, Lohmann E, Atasoy IL, Candas E, Araz OS, Onal B, Gurvit H, Yilmazer S, Gezen-Ak D (2016) Vitamin D deficiency might pose a greater risk for ApoEvarepsilon4 non-carrier Alzheimer\u2019s disease patients. Neurol Sci 37(10):1633\u20131643","journal-title":"Neurol Sci"},{"issue":"1","key":"86_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12017-016-8415-9","volume":"19","author":"D Gezen-Ak","year":"2017","unstructured":"Gezen-Ak D, Alaylioglu M, Genc G, Gunduz A, Candas E, Bilgic B, Atasoy IL, Apaydin H, Kiziltan G, Gurvit H, Hanagasi H, Ertan S, Yilmazer S, Dursun E (2017) GC and VDR SNPs and vitamin D levels in Parkinson\u2019s disease: the relevance to clinical features. NeuroMolecular Med 19(1):24\u201340","journal-title":"NeuroMolecular Med"},{"issue":"10","key":"86_CR13","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1021\/acschemneuro.7b00245","volume":"8","author":"D Gezen-Ak","year":"2017","unstructured":"Gezen-Ak D, Atasoy IL, Candas E, Alaylioglu M, Yilmazer S, Dursun E (2017) Vitamin D receptor regulates amyloid beta 1-42 production with protein disulfide isomerase A3. ACS Chem Neurosci 8(10):2335\u20132346","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"86_CR14","first-page":"265","volume":"14","author":"C Annweiler","year":"2016","unstructured":"Annweiler C, Dursun E, Feron F, Gezen-Ak D, Kalueff AV, Littlejohns T, Llewellyn D, Millet P, Scott T, Tucker KL, Yilmazer S, Beauchet O (2016) Vitamin D and cognition in older adults: international consensus guidelines. Geriatr Psychol Neuropsychiatr Vieil 14(3):265\u2013273","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"},{"issue":"1","key":"86_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/joim.12279","volume":"277","author":"C Annweiler","year":"2015","unstructured":"Annweiler C, Dursun E, Feron F, Gezen-Ak D, Kalueff AV, Littlejohns T, Llewellyn DJ, Millet P, Scott T, Tucker KL, Yilmazer S, Beauchet O (2015) \u2018Vitamin D and cognition in older adults\u2019: updated international recommendations. J Intern Med 277(1):45\u201357","journal-title":"J Intern Med"},{"key":"86_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0304-3940(01)02130-9","volume":"310","author":"SE Poduslo","year":"2001","unstructured":"Poduslo SE, Yin X (2001) Chromosome 12 and late onset Alzheimer\u2019s disease. Neurosci Lett 310:188\u2013190","journal-title":"Neurosci Lett"},{"key":"86_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/1243","volume":"19","author":"D Blacker","year":"1998","unstructured":"Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, Go RC, Perry R, Watson B Jr, Bassett SS, McInnis MG, Albert MS, Hyman BT, Tanzi RE (1998) Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 19:357\u2013360","journal-title":"Nat Genet"},{"key":"86_CR18","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1212\/WNL.50.6.1905","volume":"50","author":"E Hollenbach","year":"1998","unstructured":"Hollenbach E, Ackermann S, Hyman BT, Rebeck GW (1998) Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer\u2019s disease. Neurology 50:1905\u20131907","journal-title":"Neurology"},{"key":"86_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ajmg.b.10026","volume":"117B","author":"E Luedecking-Zimmer","year":"2003","unstructured":"Luedecking-Zimmer E, DeKosky S, Nebes R, Kamboh I (2003) Association of the 3\u2019UTR transcription factor LBP-1c\/CP2\/LSF polymorphism with late-onset Alzheimer\u2019s disease. Am J Med Genet B Neuropsychiatr Genet 117B:114\u2013117","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"86_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ajhg.2008.12.008","volume":"84","author":"GW Beecham","year":"2009","unstructured":"Beecham GW, Martin ER, Li YJ, Slifer MA, Gilbert JR, Haines JL, Pericak-Vance MA (2009) Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am J Hum Genet 84:35\u201343","journal-title":"Am J Hum Genet"},{"issue":"3","key":"86_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1620\/tjem.212.275","volume":"212","author":"D Gezen-Ak","year":"2007","unstructured":"Gezen-Ak D, Dursun E, Ertan T, Hanagasi H, Gurvit H, Emre M, Eker E, Ozturk M, Engin F, Yilmazer S (2007) Association between vitamin D receptor gene polymorphism and Alzheimer\u2019s disease. Tohoku J Exp Med 212(3):275\u2013282","journal-title":"Tohoku J Exp Med"},{"key":"86_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/0891988708324941","volume":"21","author":"E Dursun","year":"2008","unstructured":"Dursun E, Gezen- Ak D, Eker E, Ertan T, Engin F, Hanagasi H, G\u00fcrvit H, Emre M, Yilmazer S (2008) Presenilin-1 gene intronic polymorphism and late-onset Alzheimer\u2019s disease. J Geriatr Psychiatry Neurol 21:268\u2013273","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"86_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000193627","volume":"27","author":"E Dursun","year":"2009","unstructured":"Dursun E, Gezen-Ak D, Ertan T, Bilgi\u00e7 B, G\u00fcrvit H, Emre M, Eker E, Engin F, Uysal \u00d6, Y\u0131lmazer S (2009) Interleukin-1\u03b1\u2013889 C\/T polymorphism in Turkish patients with late-onset Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 27:82\u201387","journal-title":"Dement Geriatr Cogn Disord"},{"key":"86_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1155\/2005\/645260","volume":"21","author":"D Gezen-Ak","year":"2005","unstructured":"Gezen-Ak D, Kahraman H, Dursun E, S\u00fcsleyici Duman B, Erensoy N, Alag\u00f6l F, Y\u0131lmazer S (2005) Polymorphisms at the ligand binding sites of vitamin D receptor gene and osteomalacia. Dis Markers 21:191\u2013197","journal-title":"Dis Markers"},{"issue":"3","key":"86_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1620\/tjem.228.189","volume":"228","author":"D Gezen-Ak","year":"2012","unstructured":"Gezen-Ak D, Dursun E, Bilgic B, Hanagasi H, Ertan T, Gurvit H, Emre M, Eker E, Ulutin T, Uysal O, Yilmazer S (2012) Vitamin D receptor gene haplotype is associated with late-onset Alzheimer\u2019s disease. Tohoku J Exp Med 228(3):189\u2013196","journal-title":"Tohoku J Exp Med"},{"issue":"2","key":"86_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.gene.2004.05.014","volume":"338","author":"AG Uitterlinden","year":"2004","unstructured":"Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338(2):143\u2013156","journal-title":"Gene"},{"key":"86_CR27","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.neurobiolaging.2007.07.001","volume":"30","author":"M Kuningas","year":"2009","unstructured":"Kuningas M, Mooijaart SP, Jolles J, Slagboom PE, Westendorp RGJ, Van Heemst D (2009) VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol Aging 30:466\u2013473","journal-title":"Neurobiol Aging"},{"key":"86_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3945\/ajcn.111.017137","volume":"95","author":"MA Beydoun","year":"2012","unstructured":"Beydoun MA, Ding EL, Beydoun HA, Tanaka T, Ferrucci L, Zonderman AB (2012) Vitamin D receptor and megalin gene polymorphisms and their associations with longitudinal cognitive change in US adults. Am J Clin Nutr 95:163\u2013178","journal-title":"Am J Clin Nutr"},{"key":"86_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neulet.2011.08.057","volume":"504","author":"DJ Lehmann","year":"2011","unstructured":"Lehmann DJ, Refsum H, Warden DR, Medway C, Wilcock GK, Smith DA (2011) The vitamin D receptor gene is associated with Alzheimer\u2019s disease. Neurosci Lett 504:79\u201382","journal-title":"Neurosci Lett"},{"issue":"2","key":"86_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1469-1809.2010.00631.x","volume":"75","author":"MW Butler","year":"2011","unstructured":"Butler MW, Burt A, Edwards TL, Zuchner S, Scott WK, Martin ER, Vance JM, Wang L (2011) Vitamin D receptor gene as a candidate gene for Parkinson disease. Ann Hum Genet 75(2):201\u2013210","journal-title":"Ann Hum Genet"},{"issue":"4","key":"86_CR31","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ajmg.b.31056","volume":"153B","author":"T Vargas","year":"2010","unstructured":"Vargas T, Bullido MJ, Martinez-Garcia A, Antequera D, Clarimon J, Rosich-Estrago M, Martin-Requero A, Mateo I, Rodriguez-Rodriguez E, Vilella-Cuadrada E, Frank A, Lleo A, Molina-Porcel L, Blesa R, Combarros O, Gomez-Isla T, Bermejo-Pareja F, Valdivieso F, Carro E (2010) A megalin polymorphism associated with promoter activity and Alzheimer\u2019s disease risk. Am J Med Genet B Neuropsychiatr Genet 153B(4):895\u2013902","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"3\u20134","key":"86_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.cca.2010.10.015","volume":"412","author":"LL Wang","year":"2011","unstructured":"Wang LL, Pan XL, Wang Y, Tang HD, Deng YL, Ren RJ, Xu W, Ma JF, Wang G, Chen SD (2011) A single nucleotide polymorphism in LRP2 is associated with susceptibility to Alzheimer\u2019s disease in the Chinese population. Clin Chim Acta 412(3\u20134):268\u2013270","journal-title":"Clin Chim Acta"},{"issue":"3","key":"86_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0169-328X(92)90032-7","volume":"13","author":"MK Sutherland","year":"1992","unstructured":"Sutherland MK, Somerville MJ, Yoong LK, Bergeron C, Haussler MR, McLachlan DR (1992) Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res 13(3):239\u2013250","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"86_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/JAD-2010-101377","volume":"23","author":"E Dursun","year":"2011","unstructured":"Dursun E, Gezen-Ak D, Yilmazer S (2011) A novel perspective for Alzheimer\u2019s disease: vitamin D receptor suppression by amyloid-beta and preventing the amyloid-beta induced alterations by vitamin D in cortical neurons. J Alzheimers Dis 23(2):207\u2013219","journal-title":"J Alzheimers Dis"},{"issue":"1\u20132","key":"86_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000350319","volume":"36","author":"E Dursun","year":"2013","unstructured":"Dursun E, Gezen-Ak D, Yilmazer S (2013) Beta amyloid suppresses the expression of the vitamin d receptor gene and induces the expression of the vitamin d catabolic enzyme gene in hippocampal neurons. Dement Geriatr Cogn Disord 36(1\u20132):76\u201386","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"8","key":"86_CR36","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s10072-012-1268-6","volume":"34","author":"D Gezen-Ak","year":"2013","unstructured":"Gezen-Ak D, Dursun E, Yilmazer S (2013) Vitamin D inquiry in hippocampal neurons: consequences of vitamin D-VDR pathway disruption on calcium channel and the vitamin D requirement. Neurol Sci 34(8):1453\u20131458","journal-title":"Neurol Sci"},{"key":"86_CR37","doi-asserted-by":"publisher","unstructured":"Gezen-Ak D, Dursun E, Yilmazer S (2013) The effect of vitamin D treatement on nevre growth factor release (NGF) in hippocampal neurons. Arch Neuropsych. https:\/\/doi.org\/10.4274\/npa.y7076","DOI":"10.4274\/npa.y7076"},{"key":"86_CR38","doi-asserted-by":"publisher","unstructured":"Dursun E, Gezen-Ak D, Yilmazer S (2013) The influence of vitamin D treatment on the inducible nitric oxide synthase expression in primary hippocampal neurons. Arch Neuropsych 51(2):163\u2013168. https:\/\/doi.org\/10.4274\/npa.y7089","DOI":"10.4274\/npa.y7089"},{"issue":"11","key":"86_CR39","doi-asserted-by":"publisher","first-page":"e0188605","DOI":"10.1371\/journal.pone.0188605","volume":"12","author":"E Dursun","year":"2017","unstructured":"Dursun E, Gezen-Ak D (2017) Vitamin D receptor is present on the neuronal plasma membrane and is co-localized with amyloid precursor protein, ADAM10 or Nicastrin. PLoS One 12(11):e0188605","journal-title":"PLoS One"},{"issue":"3","key":"86_CR40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-130416","volume":"36","author":"E Dursun","year":"2013","unstructured":"Dursun E, Gezen-Ak D, Yilmazer S (2013) A new mechanism for amyloid-beta induction of iNOS: vitamin D-VDR pathway disruption. J Alzheimers Dis 36(3):459\u2013474","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"86_CR41","doi-asserted-by":"publisher","first-page":"e17553","DOI":"10.1371\/journal.pone.0017553","volume":"6","author":"D Gezen-Ak","year":"2011","unstructured":"Gezen-Ak D, Dursun E, Yilmazer S (2011) The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons. PLoS One 6(3):e17553","journal-title":"PLoS One"},{"issue":"3","key":"86_CR42","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12017-018-8498-6","volume":"20","author":"D Gezen-Ak","year":"2018","unstructured":"Gezen-Ak D, Atasoy IL, Candas E, Alaylioglu M, Dursun E (2018) The transcriptional regulatory properties of amyloid beta 1-42 may include regulation of genes related to neurodegeneration. NeuroMolecular Med 20(3):363\u2013375","journal-title":"NeuroMolecular Med"},{"issue":"1","key":"86_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3233\/JAD-2012-110560","volume":"29","author":"MT Mizwicki","year":"2011","unstructured":"Mizwicki MT, Menegaz D, Zhang J, Barrientos-Dur\u00e1n A, Tse S, Cashman JR, Griffin PR, Fiala M (2011) Genomic and nongenomic signaling induced by 1\u03b1,25(OH)2-vitamin D3 promotes the recovery of amyloid-\u03b2 phagocytosis by Alzheimer\u2019s disease macrophages. J Alzheimers Dis 29(1):51\u201362","journal-title":"J Alzheimers Dis"},{"key":"86_CR44","doi-asserted-by":"crossref","unstructured":"Grimm MOW, Thiel A, Lauer AA, Winkler J, Lehmann J, Regner L, Nelke C, Janitschke D, Benoist C, Streidenberger O, Stotzel H, Endres K, Herr C, Beisswenger C, Grimm HS, Bals R, Lammert F, Hartmann T (2017) Vitamin D and its analogues decrease amyloid-beta (Abeta) formation and increase Abeta-degradation. Int J Mol Sci 18(12)","DOI":"10.3390\/ijms18122764"},{"key":"86_CR45","doi-asserted-by":"publisher","unstructured":"Landel V, Stephan D, Cui X, Eyles D, Feron F (2017) Differential expression of vitamin D-associated enzymes and receptors in brain cell subtypes. J Steroid Biochem Mol Biol 177:129\u2013134. https:\/\/doi.org\/10.1016\/j.jsbmb.2017.09.008","DOI":"10.1016\/j.jsbmb.2017.09.008"},{"issue":"2","key":"86_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1124\/pr.116.013227","volume":"69","author":"MJ Berridge","year":"2017","unstructured":"Berridge MJ (2017) Vitamin D and depression: cellular and regulatory mechanisms. Pharmacol Rev 69(2):80\u201392","journal-title":"Pharmacol Rev"},{"issue":"2","key":"86_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3233\/JAD-2011-101986","volume":"25","author":"J Yu","year":"2011","unstructured":"Yu J, Gattoni-Celli M, Zhu H, Bhat NR, Sambamurti K, Gattoni-Celli S, Kindy MS (2011) Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of A\u03b2PP transgenic mice. J Alzheimers Dis 25(2):295\u2013307","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"86_CR48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.brainresbull.2004.12.007","volume":"65","author":"F F\u2019eron","year":"2005","unstructured":"F\u2019eron F, Burne THJ, Brown J, Smith E, McGrath JJ, Mackay-Sima A, Eyles DW (2005) Developmental Vitamin D3 deficiency alters the adult rat brain. Brain Res Bull 65(2):141\u2013148","journal-title":"Brain Res Bull"},{"issue":"1","key":"86_CR49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.psyneuen.2009.05.023","volume":"34","author":"DA Fernandes de Abreu","year":"2009","unstructured":"Fernandes de Abreu DA, Eyles D, F\u00e9ron F, Vitamin D (2009) a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 34(1):265\u2013277","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"86_CR50","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1258\/ebm.2010.010014","volume":"235","author":"AW Norman","year":"2010","unstructured":"Norman AW, Bouillon R (2010) Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood) 235(9):1034\u20131045","journal-title":"Exp Biol Med (Maywood)"},{"key":"86_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11926-008-0020-y","volume":"10","author":"N Khazai","year":"2008","unstructured":"Khazai N, Judd SE, Tangpricha V (2008) Calcium and vitamin D: skeletal and extraskeletal health. Curr Rheumatol Rep 10:110\u2013117","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"86_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1212\/WNL.0b013e3181beecd3","volume":"74","author":"C Annweiler","year":"2010","unstructured":"Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW, Allain P, Herrmann FR, Beauchet O (2010) Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 74(1):27\u201332","journal-title":"Neurology"},{"issue":"6","key":"86_CR53","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/BF02982668","volume":"12","author":"EP Cherniack","year":"2008","unstructured":"Cherniack EP, Florez H, Roos BA, Troen BR, Levis S (2008) Hypovitaminosis D in the elderly: from bone to brain. J Nutr Health Aging 12(6):366\u2013373","journal-title":"J Nutr Health Aging"},{"issue":"10","key":"86_CR54","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1001\/archneur.65.10.1348","volume":"65","author":"ML Evatt","year":"2008","unstructured":"Evatt ML, DeLong MR, Khazai N, Rosen A, Triche S, Tangpricha V (2008) Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 65(10):1348\u20131352","journal-title":"Arch Neurol"},{"issue":"3","key":"86_CR55","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/0891988708327888","volume":"22","author":"DJ Llewellyn","year":"2009","unstructured":"Llewellyn DJ, Langa KM, Lang IA (2009) Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 22(3):188\u2013195","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"13","key":"86_CR56","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1001\/archinternmed.2010.173","volume":"170","author":"DJ Llewellyn","year":"2010","unstructured":"Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, Cherubini A, Ferrucci L, Melzer D, Vitamin D (2010) Risk of cognitive decline in elderly persons. Arch Intern Med 170(13):1135\u20131141","journal-title":"Arch Intern Med"},{"key":"86_CR57","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1096\/fj.07-9326rev","volume":"22","author":"J McCann","year":"2008","unstructured":"McCann J, Ames BN (2008) Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 22:982\u20131001","journal-title":"FASEB J"},{"key":"86_CR58","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1097\/01.JGP.0000240986.74642.7c","volume":"14","author":"CH Wilkins","year":"2006","unstructured":"Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC (2006) Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 14:1032\u20131040","journal-title":"Am J Geriatr Psychiatry"},{"key":"86_CR59","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1159\/000134382","volume":"25","author":"C Oudshoorn","year":"2008","unstructured":"Oudshoorn C, Mattace-Raso FUS, van der Velde N, Colin EM, van der Cammen TJM (2008) Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 25:539\u2013543","journal-title":"Dement Geriatr Cogn Disord"},{"key":"86_CR60","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000334944","volume":"32","author":"C Annweiler","year":"2012","unstructured":"Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Beauchet O (2012) Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. Dement Geriatr Cogn Disord 32:273\u2013278","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"7","key":"86_CR61","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1468-1331.2012.03675.x","volume":"19","author":"C Annweiler","year":"2012","unstructured":"Annweiler C, Fantino B, Schott AM, Krolak-Salmon P, Allali G, Beauchet O (2012) Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. Eur J Neurol 19(7):1023\u20131029","journal-title":"Eur J Neurol"},{"issue":"1","key":"86_CR62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/JAD-130452","volume":"37","author":"C Annweiler","year":"2013","unstructured":"Annweiler C, Montero-Odasso M, Llewellyn DJ, Richard-Devantoy S, Duque G, Beauchet O (2013) Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J Alzheimers Dis 37(1):147\u2013171","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"86_CR63","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3233\/JAD-2012-121432","volume":"33","author":"C Annweiler","year":"2013","unstructured":"Annweiler C, Llewellyn DJ, Beauchet O (2013) Low serum vitamin D concentrations in Alzheimer\u2019s disease: a systematic review and meta-analysis. J Alzheimers Dis 33(3):659\u2013674","journal-title":"J Alzheimers Dis"},{"key":"86_CR64","doi-asserted-by":"publisher","unstructured":"Afzal S, Bojesen SE, Nordestgaard BG (2013) Reduced 25-hydroxyvitamin D and risk of Alzheimer\u2019s disease and vascular dementia. Alzheimers Dement 10(3):296\u2013302. https:\/\/doi.org\/10.1016\/j.jalz.2013.05.1765","DOI":"10.1016\/j.jalz.2013.05.1765"},{"issue":"3","key":"86_CR65","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3233\/JAD-2009-1080","volume":"17","author":"A Masoumi","year":"2009","unstructured":"Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J, Abel K, Zheng X, Espinosa-Jeffrey A, Mahanian M, Liu PT, Hewison M, Mizwickie M, Cashman J, Fiala M (2009) 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer\u2019s disease patients. J Alzheimers Dis 17(3):703\u2013717","journal-title":"J Alzheimers Dis"},{"key":"86_CR66","doi-asserted-by":"crossref","unstructured":"Fiala M, Mizwicki MT (2011) Neuroprotective and immune effects of active forms of vitamin D3 and docosahexaenoic acid in Alzheimer disease patients. Functional Foods in Health and Disease (12):545\u2013554","DOI":"10.31989\/ffhd.v1i12.107"},{"key":"86_CR67","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/1745-6215-12-230","volume":"12","author":"C Annweiler","year":"2011","unstructured":"Annweiler C, Fantino B, Parot-Schinkel E, Thiery S, Gautier J, Beauchet O (2011) Alzheimer\u2019s disease--input of vitamin D with memantine assay (AD-IDEA trial): study protocol for a randomized controlled trial. Trials 12:230","journal-title":"Trials"},{"issue":"1","key":"86_CR68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1212\/WNL.0b013e3181beecb7","volume":"74","author":"JS Buell","year":"2010","unstructured":"Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, Bergethon P, Rosenberg IH, Folstein MF, Patz S, Bhadelia RA, Tucker KL (2010) 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 74(1):18\u201326","journal-title":"Neurology"},{"issue":"6","key":"86_CR69","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1161\/STROKEAHA.111.636910","volume":"43","author":"Q Sun","year":"2012","unstructured":"Sun Q, Pan A, Hu FB, Manson JE, Rexrode KM (2012) 25-Hydroxyvitamin D levels and the risk of stroke: a prospective study and meta-analysis. Stroke 43(6):1470\u20131477","journal-title":"Stroke"},{"issue":"1","key":"86_CR70","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/ana.23738","volume":"73","author":"P Brondum-Jacobsen","year":"2013","unstructured":"Brondum-Jacobsen P, Nordestgaard BG, Schnohr P, Benn M (2013) 25-hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann Neurol 73(1):38\u201347","journal-title":"Ann Neurol"},{"issue":"3","key":"86_CR71","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/archneurol.2008.596","volume":"66","author":"T Tapiola","year":"2009","unstructured":"Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttila T (2009) Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66(3):382\u2013389","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"86_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-8981(03)00121-9","volume":"332","author":"M Sjogren","year":"2003","unstructured":"Sjogren M, Andreasen N, Blennow K (2003) Advances in the detection of Alzheimer\u2019s disease-use of cerebrospinal fluid biomarkers. Clin Chim Acta 332(1\u20132):1\u201310","journal-title":"Clin Chim Acta"},{"issue":"3","key":"86_CR73","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3233\/JAD-2006-9309","volume":"9","author":"F Abdi","year":"2006","unstructured":"Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R, Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, Jin J, Zhu D, Li GJ, Liu Y, Waichunas D, Montine TJ, Zhang J (2006) Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis 9(3):293\u2013348","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"86_CR74","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/cdd.2012.161","volume":"20","author":"M Moon","year":"2013","unstructured":"Moon M, Song H, Hong HJ, Nam DW, Cha MY, Oh MS, Yu J, Ryu H, Mook-Jung I (2013) Vitamin D-binding protein interacts with Abeta and suppresses Abeta-mediated pathology. Cell Death Differ 20(4):630\u2013638","journal-title":"Cell Death Differ"},{"key":"86_CR75","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1309\/W01Y0B808EMEH12L","volume":"129","author":"J Zhang","year":"2008","unstructured":"Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ (2008) CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol 129:526\u2013529","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"86_CR76","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2174\/1567205015666171227154636","volume":"15","author":"CD SanMartin","year":"2018","unstructured":"SanMartin CD, Henriquez M, Chacon C, Ponce DP, Salech F, Rogers NK, Behrens MI (2018) Vitamin D increases Abeta140 plasma levels and protects lymphocytes from oxidative death in mild cognitive impairment patients. Curr Alzheimer Res 15(6):561\u2013569","journal-title":"Curr Alzheimer Res"},{"key":"86_CR77","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jsbmb.2016.12.019","volume":"175","author":"P Lemire","year":"2018","unstructured":"Lemire P, Brangier A, Beaudenon M, Duval GT, Annweiler C (2018) Cognitive changes under memantine according to vitamin D status in Alzheimer patients: an exposed\/unexposed cohort pilot study. J Steroid Biochem Mol Biol 175:151\u2013156","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"86_CR78","first-page":"94","volume":"59","author":"AK Gangwar","year":"2015","unstructured":"Gangwar AK, Rawat A, Tiwari S, Tiwari SC, Narayan J, Tiwari S (2015) Role of vitamin-D in the prevention and treatment of Alzheimer\u2019s disease. Indian J Physiol Pharmacol 59(1):94\u201399","journal-title":"Indian J Physiol Pharmacol"},{"issue":"114","key":"86_CR79","first-page":"85","volume":"25","author":"M Chaves","year":"2014","unstructured":"Chaves M, Toral A, Bisonni A, Rojas JI, Fernandez C, Garcia Basalo MJ, Matusevich D, Cristiano E, Golimstok A (2014) Treatment with vitamin D and slowing of progression to severe stage of Alzheimer\u2019s disease. Vertex 25(114):85\u201391","journal-title":"Vertex"},{"issue":"10","key":"86_CR80","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1212\/WNL.0000000000000755","volume":"83","author":"TJ Littlejohns","year":"2014","unstructured":"Littlejohns TJ, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PH, Fried L, Kestenbaum BR, Kuller LH, Langa KM, Lopez OL, Kos K, Soni M, Llewellyn DJ (2014) Vitamin D and the risk of dementia and Alzheimer disease. Neurology 83(10):920\u2013928","journal-title":"Neurology"},{"issue":"3","key":"86_CR81","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3233\/JAD-170407","volume":"60","author":"S Licher","year":"2017","unstructured":"Licher S, de Bruijn R, Wolters FJ, Zillikens MC, Ikram MA, Ikram MK (2017) Vitamin D and the risk of dementia: the Rotterdam study. J Alzheimers Dis 60(3):989\u2013997","journal-title":"J Alzheimers Dis"},{"key":"86_CR82","doi-asserted-by":"publisher","unstructured":"Jayedi A, Rashidy-Pour A, Shab-Bidar S (2018) Vitamin D status and risk of dementia and Alzheimer\u2019s disease: a meta-analysis of dose-response. Nutr Neurosci 1\u201310. https:\/\/doi.org\/10.1080\/1028415X.2018.1436639","DOI":"10.1080\/1028415X.2018.1436639"},{"issue":"10","key":"86_CR83","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jalz.2017.01.025","volume":"13","author":"C Amadieu","year":"2017","unstructured":"Amadieu C, Lefevre-Arbogast S, Delcourt C, Dartigues JF, Helmer C, Feart C, Samieri C (2017) Nutrient biomarker patterns and long-term risk of dementia in older adults. Alzheimers Dement 13(10):1125\u20131132","journal-title":"Alzheimers Dement"},{"issue":"8","key":"86_CR84","doi-asserted-by":"publisher","first-page":"1844 e1","DOI":"10.1016\/j.neurobiolaging.2011.12.038","volume":"33","author":"L Wang","year":"2012","unstructured":"Wang L, Hara K, Van Baaren JM, Price JC, Beecham GW, Gallins PJ, Whitehead PL, Wang G, Lu C, Slifer MA, Zuchner S, Martin ER, Mash D, Haines JL, Pericak-Vance MA, Gilbert JR (2012) Vitamin D receptor and Alzheimer\u2019s disease: a genetic and functional study. Neurobiol Aging 33(8):1844 e1\u20131844 e9","journal-title":"Neurobiol Aging"},{"issue":"12","key":"86_CR85","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s10072-014-1868-4","volume":"35","author":"YH Lee","year":"2014","unstructured":"Lee YH, Kim JH, Song GG (2014) Vitamin D receptor polymorphisms and susceptibility to Parkinson\u2019s disease and Alzheimer\u2019s disease: a meta-analysis. Neurol Sci 35(12):1947\u20131953","journal-title":"Neurol Sci"},{"issue":"6","key":"86_CR86","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3945\/jn.116.244962","volume":"147","author":"MA Beydoun","year":"2017","unstructured":"Beydoun MA, Tajuddin SM, Dore GA, Canas JA, Beydoun HA, Evans MK, Zonderman AB (2017) Vitamin D receptor and megalin gene polymorphisms are associated with longitudinal cognitive change among African-American urban adults. J Nutr 147(6):1048\u20131062","journal-title":"J Nutr"},{"issue":"9","key":"86_CR87","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1084\/jem.20051529","volume":"202","author":"C Nathan","year":"2005","unstructured":"Nathan C, Calingasan N, Nezezon J, Ding A, Lucia MS, La Perle K, Fuortes M, Lin M, Ehrt S, Kwon NS, Chen J, Vodovotz Y, Kipiani K, Beal MF (2005) Protection from Alzheimer\u2019s-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J Exp Med 202(9):1163\u20131169","journal-title":"J Exp Med"},{"key":"86_CR88","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom PEM, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O\u2019Banion MK, Pachter J, Pasinetti GP-SC, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer\u2019s disease. Neurobiol Aging 21:383\u2013421","journal-title":"Neurobiol Aging"},{"key":"86_CR89","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0169-409X(02)00162-X","volume":"54","author":"AH Moore","year":"2002","unstructured":"Moore AH, O\u2019Banion MK (2002) Neuroinflammation and anti-inflammatory therapy for Alzheimer\u2019s disease. Adv Drug Deliv Rev 54:1627\u20131656","journal-title":"Adv Drug Deliv Rev"},{"key":"86_CR90","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/jnr.10253","volume":"69","author":"YB Lee","year":"2002","unstructured":"Lee YB, Nagai A, Kim SU (2002) Cytokines, chemokines and cytokine receptors in human microglia. J Neurosci Res 69:94\u2013103","journal-title":"J Neurosci Res"},{"key":"86_CR91","doi-asserted-by":"publisher","unstructured":"Thota C, Farmer T, Garfield RE, Menon R, Al-Hendy A (2012) Vitamin D elicits anti-inflammatory response, inhibits contractile-associated proteins, and modulates Toll-like receptors in human myometrial cells. Reprod Sci. https:\/\/doi.org\/10.1177\/1933719112459225","DOI":"10.1177\/1933719112459225"},{"issue":"17","key":"86_CR92","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1128\/MCB.05020-11","volume":"31","author":"S Joshi","year":"2011","unstructured":"Joshi S, Pantalena LC, Liu XK, Gaffen SL, Liu H, Rohowsky-Kochan C, Ichiyama K, Yoshimura A, Steinman L, Christakos S, Youssef S (2011) 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol 31(17):3653\u20133669","journal-title":"Mol Cell Biol"},{"issue":"2","key":"86_CR93","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3233\/JAD-150943","volume":"53","author":"V Landel","year":"2016","unstructured":"Landel V, Annweiler C, Millet P, Morello M, Feron F (2016) Vitamin D, cognition and Alzheimer\u2019s disease: the therapeutic benefit is in the D-tails. J Alzheimers Dis 53(2):419\u2013444","journal-title":"J Alzheimers Dis"},{"key":"86_CR94","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13024-016-0087-2","volume":"11","author":"V Landel","year":"2016","unstructured":"Landel V, Millet P, Baranger K, Loriod B, Feron F (2016) Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer\u2019s disease. Mol Neurodegener 11:22","journal-title":"Mol Neurodegener"},{"issue":"1","key":"86_CR95","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3233\/JAD-121735","volume":"34","author":"MT Mizwicki","year":"2013","unstructured":"Mizwicki MT, Liu G, Fiala M, Magpantay L, Sayre J, Siani A, Mahanian M, Weitzman R, Hayden EY, Rosenthal MJ, Nemere I, Ringman J, Teplow DB (2013) 1alpha,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-beta phagocytosis and inflammation in Alzheimer\u2019s disease patients. J Alzheimers Dis 34(1):155\u2013170","journal-title":"J Alzheimers Dis"},{"key":"86_CR96","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1742-2094-9-244","volume":"9","author":"TL Briones","year":"2012","unstructured":"Briones TL, Darwish H (2012) Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden. J Neuroinflammation 9:244","journal-title":"J Neuroinflammation"},{"key":"86_CR97","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.nbd.2003.10.010","volume":"15","author":"P Fernandez-Vizarra","year":"2004","unstructured":"Fernandez-Vizarra P, Fernandez AP, Castro-Blanco S, Encinas JM, Serrano J, Bentura ML, Munoz P, Martinez-Murillo R, Rodrigo J (2004) Expression of nitric oxide system in clinically evaluated cases of Alzheimer\u2019s disease. Neurobiol Dis 15:287\u2013305","journal-title":"Neurobiol Dis"},{"key":"86_CR98","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0006-8993(02)03280-8","volume":"953","author":"HJ Luth","year":"2002","unstructured":"Luth HJ, Munch G, Arendt T (2002) Aberrant expression of NOS isoforms in Alzheimer\u2019s disease is structurally related to nitrotyrosine formation. Brain Res 953:135\u2013143","journal-title":"Brain Res"},{"issue":"11","key":"86_CR99","doi-asserted-by":"publisher","first-page":"7918","DOI":"10.1074\/jbc.275.11.7918","volume":"275","author":"KT Akama","year":"2000","unstructured":"Akama KT, Van Eldik LJ (2000) Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism. J Biol Chem 275(11):7918\u20137924","journal-title":"J Biol Chem"},{"issue":"2","key":"86_CR100","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0169-328X(96)00260-4","volume":"45","author":"E Garcion","year":"1997","unstructured":"Garcion E, Nataf S, Berod A, Darcy F, Brachet P (1997) 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res Mol Brain Res 45(2):255\u2013267","journal-title":"Brain Res Mol Brain Res"},{"issue":"3","key":"86_CR101","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/(SICI)1098-1136(199803)22:3<282::AID-GLIA7>3.0.CO;2-7","volume":"22","author":"E Garcion","year":"1998","unstructured":"Garcion E, Sindji L, Montero-Menei C, Andre C, Brachet P, Darcy F (1998) Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3. Glia 22(3):282\u2013294","journal-title":"Glia"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0086-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s42000-018-0086-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0086-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T19:52:08Z","timestamp":1720813928000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s42000-018-0086-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1007\/s42000-018-0086-5","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"assertion":[{"value":"22 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}